SMC
STJ

S. Muoio & Co’s St Jude Medical STJ Stock Holding History

S. Muoio & Co’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-100,000
Closed -$8.02M – 107
2016
Q4 		$8.02M Buy
100,000
+40,000
+67% +$3.17M 4.18% 3
2016
Q3 		$4.79M Buy
60,000
+10,000
+20% +$807K 2.36% 7
2016
Q2 		$3.9M Buy
+50,000
New +$3.57M 1.84% 13

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

S. Muoio & Co's STJ Position: Q1 2017 in Review

S. Muoio & Co sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 100,000 shares — an estimated $8.02M sold.

S. Muoio & Co first reported a position in STJ in Q2 2016 and held it in 3 quarters. The position peaked at $8.02M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • S. Muoio & Co reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • S. Muoio & Co sold 100,000 St Jude Medical shares in Q1 2017, an estimated $8.02M.
  • S. Muoio & Co first reported a position in St Jude Medical in Q2 2016 and held it in 3 quarters.
  • S. Muoio & Co's St Jude Medical position peaked at $8.02M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on S. Muoio & Co's 13F filing for Q1 2017, filed 12 May 2017.